| Partner: M. Ciezkowska |
Ostatnie publikacje
| 1. | Wencel A.♦, Ciezkowska M.♦, Wisniewska M.♦, Zakrzewska K.E., Pijanowska D.G.♦, Pluta K.D.♦, Effects of genetically modified human skin fibroblasts, stably overexpressing hepatocyte growth factor, on hepatic functions of cocultured C3A cells, Biotechnology & Bioengineering, ISSN: 0006-3592, DOI: 10.1002/bit.27551, Vol.118, No.1, pp.72-81, 2021 Streszczenie: Diseases leading to terminal hepatic failure are among the most common causes of death worldwide. Transplant of the whole organ is the only effective method to cure liver failure. Unfortunately, this treatment option is not available universally due to the serious shortage of donors. Thus, alternative methods have been developed that are aimed at prolonging the life of patients, including hepatic cells transplantation and bridging therapy based on hybrid bioartificial liver devices. Parenchymal liver cells are highly differentiated and perform many complex functions, such as detoxification and protein synthesis. Unfortunately, isolated hepatocytes display a rapid decline in viability and liver‐specific functions. A number of methods have been developed to maintain hepatocytes in their highly differentiated state in vitro, amongst them the most promising being 3D growth scaffolds and decellularized tissues or coculture with other cell types required for the heterotypic cell‐cell interactions. Here we present a novel approach to the hepatic cells culture based on the feeder layer cells genetically modified using lentiviral vector to stably produce additional amounts of hepatocyte growth factor and show the positive influence of these coculture conditions on the preservation of the hepatic functions of the liver parenchymal cells' model—C3A cells. Słowa kluczowe: cell genetic modifications, growth surface engineering, hepatocyte growth factor, hepatocytes‐fibroblasts coculture, lentiviral vectors Afiliacje autorów:
|  | 100p. | |||||||||||||||||||||||||||
| 2. | Pluta K.D.♦, Samluk A.♦, Wencel A.♦, Zakrzewska K.E., Gora M.♦, Burzynska B.♦, Ciezkowska M.♦, Motyl J.♦, Pijanowska D.G.♦, Genetically modified C3A cells with restored urea cycle for improved bioartificial liver, Biocybernetics and Biomedical Engineering, ISSN: 0208-5216, DOI: 10.1016/j.bbe.2019.12.006, Vol.40, No.1, pp.378-387, 2020 Streszczenie: The bioartificial liver, a hybrid device aimed at improving the survival of patients with fulminant liver failure, requires a cell source to replicate human liver function. However, liver support systems that utilize porcine or human hepatoma-derived cells felt short of expectations in clinical trials. Here we present engineered C3A cells, with a restored function of the urea cycle, which can be used in an efficacious bioartificial liver. The genetic modification was performed using a lentiviral-mediated gene transfer which led to effective integration of the transgenes, coding for arginase I and ornithine transcarbamylase, into the target cell genomes. The engineered cells are more resistant to the oxidative/nitrosative stress induced by the presence of high concentrations of ammonia cations and produce more urea than their unmodified counterparts. Interestingly, the genetically modified cells secrete more albumin than control C3A cells and the synthesis of the protein is induced by increasing concentrations of ammonia. Although the physiological capabilities of the new cell line need to be further examined, at this stage of our study we may conclude that the genetically modified cells are able to convert ammonia to urea more effectively than regular C3A cells. Słowa kluczowe: bioartificial liver, genetically modified cells, lentiviral vectors, urea cycle Afiliacje autorów:
| | 100p. |